Red Light Holland is adding an education-based VR tool to its e-commerce platform.
Red Light Holland is adding an education-based VR tool to its e-commerce platform.
Mydecine's recent acquisition, NeuroPharm Inc, is about to commence clinical trials using psilocybin to treat PTSD.
PharmaDrug (CAN:BUZZ / US:LMLLF) and Red Light Holland (CAN:TRIP) have entered into a share exchange agreement.
NovaMind closes on a CAD$4.4 million financing, upsized from the original CAD$3.0 million placement.
This release confirms Mydecine's June 10th announcement of the acquisition of NeuroPharm Inc.
Champignon provides an update on its current trading halt and other corporate matters.
A 2018 report estimates that mental health issues could cost the global economy $16 trillion between now and 2030. Psychedelic drugs are needed to mitigate those costs.
MagicMed files with the USPTO with respect to its "broad portfolio of novel psilocybin molecular derivatives, the Psybrary™".
PharmaDrug is restructuring approximately $1 million in debt in the form of convertible debentures.
Atai Life Sciences is bolstering its R&D platform with the acquisition of New York-based Kures.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now